ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,836.22
0.16%
Dow Jones
42,297.12
0.86%
US Dollar vs MXN
20.6471
0.15%
Brent Oil
80.28
0.00%
Bitcoin
94,525.76
0.02%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Jasper Therapeutics Inc (JSPRW) Cotización

Jasper Therapeutics Inc

Jasper Therapeutics Inc (JSPRW)

NASDAQ
0.1499
-0.0101
(-6.31%)
Al cierre: 13 Enero 3:00PM
Delayed by 15 minutes
0.1499
0.00
( 0.00% )
Fuera de horario: 6:13PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
0.1499
Postura de Compra
0.1002
Postura de Venta
0.30
Volume Operado de la Acción
16,165
0.14 Rango del Día 0.1775
0.0508 Rango de 52 semanas 0.3818
Capitalización de Mercado [m]
2.249M
Precio Anterior
0.16
Precio de Apertura
0.1758
Hora
2
@
0.3
Última hora de negociación
15:13:36
Volumen financiero
US$ 2,389
Precio Promedio Ponderado
0.14778
Volumen promedio (3 m)
3,986
Acciones en circulación
15,001,353
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.56
Beneficio por acción (BPA)
-4.3
turnover
-
Beneficio neto
-64.47M

Acerca de Jasper Therapeutics Inc

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem ce... Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. Mostrar más

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.jaspertherapeutics.com
Sede
Wilmington, Delaware, USA
Fundado
-
Jasper Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker JSPRW. The last closing price for Jasper Therapeutics was US$0.16. Over the last year, Jasper Therapeutics shares have traded in a share price range of US$ 0.0508 to US$ 0.3818.

Jasper Therapeutics currently has 15,001,353 shares in issue. The market capitalisation of Jasper Therapeutics is US$2.40 million. Jasper Therapeutics has a price to earnings ratio (PE ratio) of -1.56.

JSPRW Últimas noticias

Más noticias

Form 8-K - Current report

08 Enero 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

12 Diciembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

12 Diciembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 Noviembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

15 Octubre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

12 Septiembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

12 Septiembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.069999-31.83234121120.2198990.220.101257140.16460712CS
4-0.0254-14.48944666290.17530.230.10178820.17589827CS
12-0.0491-24.67336683420.1990.25260.09096639860.18747088CS
26-0.0476-24.10126582280.19750.25260.09096643480.19658086CS
520.069987.3750.080.38180.0508120750.1728192CS
156-0.9601-86.49549549551.111.110.016174600.13667683CS
260-1.5801-91.33526011561.732.240.016208450.50956793CS

JSPRW - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Jasper Therapeutics?
El precio actual de las acciones de Jasper Therapeutics es US$ 0.1499
¿Cuántas acciones de Jasper Therapeutics están en circulación?
Jasper Therapeutics tiene 15,001,353 acciones en circulación
¿Cuál es la capitalización de mercado de Jasper Therapeutics?
La capitalización de mercado de Jasper Therapeutics es USD 2.4M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Jasper Therapeutics?
Jasper Therapeutics ha negociado en un rango de US$ 0.0508 a US$ 0.3818 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Jasper Therapeutics?
El ratio precio/beneficio de Jasper Therapeutics es -1.56
¿Cuál es la moneda de reporte de Jasper Therapeutics?
Jasper Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Jasper Therapeutics?
El último beneficio anual de Jasper Therapeutics es USD -64.47M
¿Cuál es la dirección registrada de Jasper Therapeutics?
La dirección registrada de Jasper Therapeutics es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Jasper Therapeutics?
La dirección del sitio web de Jasper Therapeutics es www.jaspertherapeutics.com
¿En qué sector industrial opera Jasper Therapeutics?
Jasper Therapeutics opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
YOSHYoshiharu Global Company
US$ 4.20
(45.83%)
97.76k
STAFStaffing 360 Solutions Inc
US$ 3.30
(45.05%)
2.11M
MNDRMobile health Network Solutions
US$ 0.5519
(35.87%)
17.49M
AREBAmerican Rebel Holdings Inc
US$ 2.70
(25.58%)
242.58k
PIIIP3 Partners Inc
US$ 0.254
(18.19%)
10.56M
AEHRAehr Test Systems
US$ 13.19
(-17.51%)
799.5k
CHEKCheck Cap Ltd
US$ 1.24
(-17.33%)
69.58k
ATPCAgape ATP Corporation
US$ 1.6399
(-16.76%)
534.43k
RZLVRezolve AI Ltd
US$ 2.0498
(-14.59%)
851.5k
GCTKGlucoTrack Inc
US$ 0.1315
(-12.16%)
19.81M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.07
(11.29%)
25.25M
GCTKGlucoTrack Inc
US$ 0.1315
(-12.16%)
19.81M
MNDRMobile health Network Solutions
US$ 0.5519
(35.87%)
17.49M
LAESSEALSQ Corporation
US$ 3.021
(-9.82%)
12.48M
PIIIP3 Partners Inc
US$ 0.254
(18.19%)
10.56M

Discusión

Ver feed completo
prototype_101 prototype_101 3 minutos hace
PkM4 Tg was subpar, see April 2023 PIC conference Slide 12
https://api.mziq.com/mzfilemanager/v2/d/307dbc8b-e212-48ba-9968-8cef3f6b5188/a1c536da-d378-05c6-0dbb-8d81ab759285?origin=1
LWLG
Mao7390 Mao7390 3 minutos hace
Monthly volume is higher than any other time in the past 13 years I believe that tells the story of what is to come here I believe it's that plain and simple load up moon shot coming 
HADV
Chartmaster Chartmaster 3 minutos hace
Cancer cure would be nice!
RONN
georgie18 georgie18 4 minutos hace
All I said is that its not tanking...70% retrace minus 1800% move = NOT TANKING...can't cherry pick a situation...include the entire picture...🥳
KULR
Chartmaster Chartmaster 5 minutos hace
should they just shut their pie hole? Ur asking for a friend, right?
SRMX
leavetheguntakethecannolis leavetheguntakethecannolis 5 minutos hace
Thank you for helping to dispel the misinformation purported here on a daily basis.
IPIX
aljafy aljafy 5 minutos hace
aljafy becomes 1st GWB jumper of 2025
IBGR
mike00h mike00h 5 minutos hace
Polska,
I, too would like to see stakes in the hearts of these corrupt, filthy rich gangsters.

RICO or not, Posner will have a lot more leverage after we are approved.
NWBO
Horseb4CarT Horseb4CarT 5 minutos hace
If it looks like a duck, and walks like a duck, and quacks like a duck, then it's most likely a duck,.... exit stage right:-)

DCVAX L is most likely a duck..... I mean following in the (waddling) footsteps of the other 90% of the treatments that have been approved after appearing in t
NWBO
Renee Renee 6 minutos hace
BRKH: SPAC Business Combination. As a result of the business combination, Each share of pre-business combination BurTech Acquisition Corp. Common Stock (OTC: BRKH) will be exchanged for one of a share of Blaize Holdings, Inc. Common Stock (Nasdaq: BZAI).

FINRA deleted symbol:
BRKH
cheynew cheynew 6 minutos hace
I got one too.
CDMO
Nogobeaver Nogobeaver 7 minutos hace
You have not met him have you?
SGTM
Chartmaster Chartmaster 7 minutos hace
So....you sound like you might be bearish here? What's UR price target then?
SRMX
Renee Renee 7 minutos hace
CLXS inactive security. FINRA deleted symbol:

https://otce.finra.org/otce/dailyList?viewType=Deletions
Lykiri Lykiri 8 minutos hace
gallium-68 (68Ga) gozetotide (a medicine for diagnostic use only to allow the imaging of prostate cancer). This medicine had its first CHM meeting on 4/25/24. It goes by the name Illuccix, and is owned by Telix Pharmaceuticals. It has been languishing in the process for a long time – this is the poo
ASX
Mjmurr13 Mjmurr13 8 minutos hace
Same 'Ole story here; the ones that believed in the company and BOD, and invested heavily in the company after the 5 hedge funds, will be the ones who will continue to lose. The amount they split speaks volumes on how much they care about their retail investors, and it will be nearly impossible for
SONX
M1Maggot M1Maggot 9 minutos hace
if we have to wait 6 weeks for just one of those useless updates we are in deep mud !
CBRF
georgie18 georgie18 9 minutos hace
CHEK...$1.24...🥳...loaded the dip...

georgie18

Member Level
Re: georgie18 post# 670207

Tuesday, January 07, 2025 10:56:27 AM

Post#
670701
of 671240
CHEK...$1.99...🥳...Breaking Out off my $1.64
CHEK
Renee Renee 9 minutos hace
CLXS: inactive security. FINRA deleted symbol:

https://otce.finra.org/otce/dailyList?viewType=Deletions
CLXS
georgie18 georgie18 9 minutos hace
CHEK...$1.24...🥳...loaded the dip...

georgie18

Member Level
Re: georgie18 post# 670207

Tuesday, January 07, 2025 10:56:27 AM

Post#
670701
of 671240
CHEK...$1.99...🥳...Breaking Out off my $1.64
CHEK
georgie18 georgie18 9 minutos hace
CHEK...$1.24...🥳...loaded the dip...

georgie18

Member Level
Re: georgie18 post# 670207

Tuesday, January 07, 2025 10:56:27 AM

Post#
670701
of 671240
CHEK...$1.99...🥳...Breaking Out off my $1.64
CHEK
delerious1 delerious1 10 minutos hace
You could see today on Level 2 Market Depth that brokers like Citadel were being more cautious with their games....like maybe they don't want to get caught in the Trips with shares to sell....and there was a new intensity with the not-so-Fab-4 here today....looked a lot like desperation
NBRI
BoilerRoom BoilerRoom 11 minutos hace
Few more days Crypto should blast off!!!  $$$$$$$$$
Snake River Dog Snake River Dog 12 minutos hace
If The Tweets Start To Turn Into Press Releases of Value!! We could See some nice movements!!
NAFS

Su Consulta Reciente

NASDAQ
JSPRW
Jasper Therapeutics
BOV
ELET6
ELETROBRAS PNB
AQSE
IQE.GB
IQE
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados